What Is the Evidence for Using Hydroxyurea for Secondary Stroke Prevention?

被引:1
作者
Lebensburger, Jeffrey D. [1 ]
DeBaun, Michael R. [2 ]
Thompson, Alexis A. [3 ]
机构
[1] Univ Alabama Birmingham, Birmingham, AL USA
[2] Vanderbilt Univ, Monroe Carell Jr Childrens Hosp, Nashville, TN 37235 USA
[3] Childrens Mem Hosp, Chicago, IL 60614 USA
关键词
SICKLE-CELL-DISEASE; BLOOD-TRANSFUSION THERAPY; RECURRENT STROKE; CHILDREN; ANEMIA; RISK;
D O I
10.1182/asheducation-2011.1.440
中图分类号
G40 [教育学];
学科分类号
040101 ; 120403 ;
摘要
A 10-year-old male patient with hemoglobin SS suffered a stroke at 7 years of age and was initially transfused at the time of presentation to lower the hemoglobin S concentration to < 30%. You are asked by the family if their child can be treated with oral hydroxyurea rather than monthly transfusions for the secondary prevention of strokes.
引用
收藏
页码:440 / 442
页数:3
相关论文
共 17 条
[1]   Chronic transfusion practice for children with sickle cell anaemia and stroke [J].
Aygun, Banu ;
McMurray, Marsha A. ;
Schultz, William H. ;
Kwiatkowski, Janet L. ;
Hilliard, Lee ;
Alvarez, Ofelia ;
Heeney, Matthew ;
Kalinyak, Karen ;
Lee, Margaret T. ;
Miller, Scott ;
Helms, Ronald W. ;
Ware, Russell E. .
BRITISH JOURNAL OF HAEMATOLOGY, 2009, 145 (04) :524-528
[2]  
COHEN AR, 1992, BLOOD, V79, P1657
[3]  
de Montalembert M, 2006, HAEMATOLOGICA, V91, P125
[4]   Long-term results using hydroxyurea/phlebotomy for reducing secondary stroke risk in children with sickle cell anemia and iron overload [J].
Greenway, Anthea ;
Ware, Russell E. ;
Thornburg, Courtney D. .
AMERICAN JOURNAL OF HEMATOLOGY, 2011, 86 (04) :357-361
[5]   Hydroxyurea for sickle cell disease in children and for prevention of cerebrovascular events: the Belgian experience [J].
Gulbis, B ;
Haberman, D ;
Dufour, D ;
Christophe, C ;
Vermylen, C ;
Kagambega, F ;
Corazza, F ;
Devalck, C ;
Dresse, MF ;
Hunninck, K ;
Klein, A ;
Le, PQ ;
Loop, M ;
Maes, P ;
Philippet, P ;
Sariban, E ;
Van Geet, C ;
Ferster, A .
BLOOD, 2005, 105 (07) :2685-2690
[6]   Silent cerebral infarcts occur despite regular blood transfusion therapy after first strokes in children with sickle cell disease [J].
Hulbert, Monica L. ;
McKinstry, Robert C. ;
Lacey, JoAnne L. ;
Moran, Christopher J. ;
Panepinto, Julie A. ;
Thompson, Alexis A. ;
Sarnaik, Sharada A. ;
Woods, Gerald M. ;
Casella, James F. ;
Inusa, Baba ;
Howard, Jo ;
Kirkham, Fenella J. ;
Anie, Kofi A. ;
Mullin, Jonathan E. ;
Ichord, Rebecca ;
Noetzel, Michael ;
Yan, Yan ;
Rodeghier, Mark ;
DeBaun, Michael R. .
BLOOD, 2011, 117 (03) :772-779
[7]  
National Heart Lung Blood Institute, 2002, MAN SICKL CELL DIS
[8]   RISK OF RECURRENT STROKE IN PATIENTS WITH SICKLE-CELL DISEASE TREATED WITH ERYTHROCYTE TRANSFUSIONS [J].
PEGELOW, CH ;
ADAMS, RJ ;
MCKIE, V ;
ABBOUD, M ;
BERMAN, B ;
MILLER, ST ;
OLIVIERI, N ;
VICHINSKY, E ;
WANG, W ;
BRAMBILLA, D .
JOURNAL OF PEDIATRICS, 1995, 126 (06) :896-899
[9]   NATURAL-HISTORY OF STROKE IN SICKLE-CELL DISEASE [J].
POWARS, D ;
WILSON, B ;
IMBUS, C ;
PEGELOW, C ;
ALLEN, J .
AMERICAN JOURNAL OF MEDICINE, 1978, 65 (03) :461-471
[10]   PERIODIC TRANSFUSIONS FOR SICKLE-CELL-ANEMIA AND CNS INFARCTION [J].
SARNAIK, S ;
SOORYA, D ;
KIM, J ;
RAVINDRANATH, Y ;
LUSHER, J .
AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1979, 133 (12) :1254-1257